| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 袁聪敏 | 中信证券 | 医药生物 | 30.84% | 24.51% | 22.66% | 100.00% | 5 | 0.00% | 2025-04-28 |
| 2 | 华挺 | 财通证券 | 医药生物 | 30.79% | 24.88% | 18.02% | -6.67% | 4 | -50.33% | 2025-06-13 |
| 3 | 张林晚 | 上海证券 | 医药生物 | 30.78% | 23.85% | 21.49% | -100.00% | 1 | -18.93% | 2025-06-18 |
| 4 | 仰佳佳 | 申万宏源 | 医药生物 | 30.69% | 27.84% | 15.25% | 23.08% | 1 | -37.64% | 2025-06-27 |
| 5 | 任晓帆 | 东海证券 | 医药生物 | 30.68% | 32.79% | 33.03% | 0.00% | 2 | -17.50% | 2025-07-09 |
| 6 | 华挺 | 财通证券 | 医药生物 | 30.61% | 24.39% | 15.42% | -6.67% | 4 | -50.33% | 2025-06-11 |
| 7 | 吴春红 | 江海证券 | 医药生物 | 30.56% | 16.93% | 8.90% | 27.27% | 6 | -25.67% | 2025-06-16 |
| 8 | 仰佳佳 | 申万宏源 | 医药生物 | 30.46% | 29.11% | 20.55% | 23.08% | 1 | -37.64% | 2025-06-06 |
| 9 | 阳景 | 浦银国际证券 | 医药生物 | 30.42% | 29.32% | 8.14% | 100.00% | 4 | 0.00% | 2025-06-26 |
| 10 | 韩世通 | 中信证券 | 医药生物 | 30.40% | 28.59% | 16.62% | -2.04% | 4 | -63.25% | 2025-06-25 |
| 11 | 王班 | 民生证券 | 医药生物 | 30.39% | 35.19% | 29.14% | -21.43% | 15 | -61.25% | 2025-07-18 |
| 12 | 仰佳佳 | 申万宏源 | 医药生物 | 30.38% | 31.12% | 22.18% | 23.08% | 1 | -37.64% | 2025-06-05 |
| 13 | 唐寅灏 | 中信证券 | 医药生物 | 30.35% | 19.83% | 20.79% | 85.71% | 12 | -8.47% | 2025-05-28 |
| 14 | 武煜 | 招银国际 | 医药生物 | 30.33% | 26.27% | 13.50% | -33.33% | 2 | -16.66% | 2025-05-21 |
| 15 | 吴春红 | 江海证券 | 医药生物 | 30.33% | 16.08% | 22.27% | 27.27% | 7 | -25.67% | 2025-05-28 |
| 16 | 唐寅灏 | 中信证券 | 医药生物 | 30.30% | 19.96% | 29.29% | 85.71% | 12 | -8.47% | 2025-05-20 |
| 17 | 阳景 | 浦银国际证券 | 医药生物 | 30.25% | 36.86% | 13.36% | 100.00% | 4 | 0.00% | 2025-07-07 |
| 18 | 吴春红 | 江海证券 | 医药生物 | 30.24% | 15.48% | 23.08% | 27.27% | 7 | -25.67% | 2025-05-15 |
| 19 | 韩世通 | 中信证券 | 医药生物 | 30.20% | 34.26% | 28.32% | -2.04% | 6 | -63.25% | 2025-07-07 |
| 20 | 周豫 | 太平洋 | 医药生物 | 30.16% | 21.13% | 20.68% | 21.21% | 23 | -55.62% | 2025-06-12 |